(OCLS)
Loading...
Symbols:
OCLS Forum Topics
- All Comments on OCLS
- General Discussion on OCLS
- Oculus Innovative Sciences, Inc. F4Q08 (Qtr End 03/31/08) Earnings Call Transcript [view article]
- Oculus Devises China Marketing Plan for Wound Healing Product [view article]
- Following the China Biopharma Beat [view article]
- A Good Start for Biotech, Two Weeks in a Row [view article]
Recent OCLS Articles
- China Biotech in Review: A Week of Collaborations
- Oculus to Use Bayer for Approval of Wound Treatment in Animals
- Following the China Biopharma Beat
- Oculus Devises China Marketing Plan for Wound Healing Product
- Downturn in China Biotech Stocks Shows No Impact on Activity
- Oculus Receives SFDA Approval for Wound Treatment
- Oculus Innovative Sciences IPO Analysis: Six Month Review
- Biotech Week-in-Review: Genentech, Amgen Take a Toll on Biotech
- Biotech Stocks Day-In-Review: Amgen Disappoints After The Bell
- IPO Watch: Oculus Seeks Foothold In Wound Healing
- Full List of Articles »
Trading Center
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
loading ...
Alpha
Transcripts
Oculus Innovative Sciences, Inc. F4Q08 (Qtr End 03/31/08) Earnings Call Transcript [view article]
Thank you for your feedback. The transcript will be reviewed again for quality assurance. We hope that you continue to enjoy our transcripts. All the best. ReplyOculus Innovative Sciences, Inc. F4Q08 (Qtr End 03/31/08) Earnings Call Transcript [view article]
Does anyone proofread these transcripts? "The India approval in the United States" ... could that be the NDA approval? And repeated a dozen times in the text. Pretty significant confusion gets generated by these errors. ReplyVilmur
General Discussion on OCLS
At the current price OCLS is a definite buy. It has products that are superior to antibiotic drugs for all external wounds that will not heal due to embedded microbes.On Apr 06 05:20 AM SeekingAlpha Editors wrote:
> Is this a buy or a sell? Reply
Vilmur
Oculus Devises China Marketing Plan for Wound Healing Product [view article]
The comment below is not very rational. Microcyn is NOT soap but a stabilized oxygen solution that was designed to kill microbes and speed up wound healing. Soap does not kill microbes but can only remove them from the suface being washed. Soap will do nothing for a wound that has embedded MRSA microbes while Microcyn can penetrate into the wound and kill the microbes.On May 23 09:59 AM razormdthe2n d wrote:
> ..."Microcyn Technology" is -- uhhhhhhhhh...soap?...H... noticed
> in their phase II studies the control group used saline!...HAW!!...well...
> uhhhh, yeah, I can see it would work better than salt water...but
> does it work better than plain old soap?...or better than other bacteriocidal
> agents already on the market?...HAW!...and then I saw that scare
> tactic MRSA page on their website!...of course, they neglect to mention
> that the best way to prevent MRSA is washing your hands with plain
> old soap and water...HAW!..."M... Technology" -- what a joke!...HAW,
> HAW, HAW!!! Reply
d
Oculus Devises China Marketing Plan for Wound Healing Product [view article]
..."Microcyn Technology" is -- uhhhhhhhhh...soap?...H... noticed in their phase II studies the control group used saline!...HAW!!...well... uhhhh, yeah, I can see it would work better than salt water...but does it work better than plain old soap?...or better than other bacteriocidal agents already on the market?...HAW!...and then I saw that scare tactic MRSA page on their website!...of course, they neglect to mention that the best way to prevent MRSA is washing your hands with plain old soap and water...HAW!..."M... Technology" -- what a joke!...HAW, HAW, HAW!!! ReplyEditors
General Discussion on OCLS
Is this a buy or a sell? ReplyCalderone
A Good Start for Biotech, Two Weeks in a Row [view article]
Cramer called this stock tonight. Says it could go to $140. Read complete review at cramersez.com or thestreet.com Reply